ZA200200280B - Mycophenolate mofetil in association with PEG-IFN-alpha. - Google Patents
Mycophenolate mofetil in association with PEG-IFN-alpha.Info
- Publication number
- ZA200200280B ZA200200280B ZA200200280A ZA200200280A ZA200200280B ZA 200200280 B ZA200200280 B ZA 200200280B ZA 200200280 A ZA200200280 A ZA 200200280A ZA 200200280 A ZA200200280 A ZA 200200280A ZA 200200280 B ZA200200280 B ZA 200200280B
- Authority
- ZA
- South Africa
- Prior art keywords
- ifn
- peg
- alpha
- association
- mycophenolate mofetil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99115950 | 1999-08-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200200280B true ZA200200280B (en) | 2003-04-11 |
Family
ID=29762814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200200280A ZA200200280B (en) | 1999-08-13 | 2002-01-11 | Mycophenolate mofetil in association with PEG-IFN-alpha. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1220683A2 (pt) |
JP (1) | JP2003507339A (pt) |
CN (1) | CN1368887A (pt) |
AU (1) | AU7408200A (pt) |
BR (1) | BR0013252A (pt) |
CA (1) | CA2380653A1 (pt) |
HU (1) | HUP0202525A3 (pt) |
MX (1) | MXPA02001296A (pt) |
PE (1) | PE20010490A1 (pt) |
PL (1) | PL357367A1 (pt) |
RU (1) | RU2002105485A (pt) |
TR (1) | TR200200401T2 (pt) |
WO (1) | WO2001012214A2 (pt) |
ZA (1) | ZA200200280B (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0307553D0 (en) * | 2003-04-01 | 2003-05-07 | Novartis Ag | Organic compounds |
US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
JP4143669B2 (ja) | 2004-02-24 | 2008-09-03 | 日本たばこ産業株式会社 | 4環縮合複素環化合物及びそのhcvポリメラーゼ阻害剤としての利用 |
US7632491B2 (en) | 2004-08-12 | 2009-12-15 | Schering Corporation | Stable pegylated interferon formulation |
US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
US8017612B2 (en) | 2006-04-18 | 2011-09-13 | Japan Tobacco Inc. | Piperazine compound and use thereof as a HCV polymerase inhibitor |
US8623348B2 (en) * | 2009-03-27 | 2014-01-07 | Jw Pharmaceutical Corporation | Interferon-α (IFN-α) fused proteins comprising IFN-α and a cytoplasmic transduction peptide (CTP) |
US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
CA2811250C (en) | 2011-10-21 | 2015-08-11 | Abbvie Inc. | Methods for treating hcv |
GB2506086A (en) | 2011-10-21 | 2014-03-19 | Abbvie Inc | Methods for treating HCV comprising at least two direct acting antiviral agent, ribavirin but not interferon |
US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
KR102540109B1 (ko) * | 2014-11-06 | 2023-06-02 | 파마에센시아 코퍼레이션 | Peg화된 인터페론의 투약 요법 |
US11192914B2 (en) | 2016-04-28 | 2021-12-07 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5908621A (en) * | 1995-11-02 | 1999-06-01 | Schering Corporation | Polyethylene glycol modified interferon therapy |
MY125300A (en) * | 1999-02-26 | 2006-07-31 | Inst Of Molecular And Cell Biology | Synergistic combination for treatment of viral-mediated diseases |
-
2000
- 2000-08-08 PE PE2000000804A patent/PE20010490A1/es not_active Application Discontinuation
- 2000-08-08 PL PL00357367A patent/PL357367A1/xx not_active Application Discontinuation
- 2000-08-08 HU HU0202525A patent/HUP0202525A3/hu unknown
- 2000-08-08 CA CA002380653A patent/CA2380653A1/en not_active Abandoned
- 2000-08-08 MX MXPA02001296A patent/MXPA02001296A/es unknown
- 2000-08-08 BR BR0013252-7A patent/BR0013252A/pt not_active IP Right Cessation
- 2000-08-08 TR TR2002/00401T patent/TR200200401T2/xx unknown
- 2000-08-08 WO PCT/EP2000/007666 patent/WO2001012214A2/en not_active Application Discontinuation
- 2000-08-08 EP EP00962297A patent/EP1220683A2/en not_active Withdrawn
- 2000-08-08 CN CN00811397A patent/CN1368887A/zh active Pending
- 2000-08-08 JP JP2001516559A patent/JP2003507339A/ja active Pending
- 2000-08-08 RU RU2002105485/15A patent/RU2002105485A/ru not_active Application Discontinuation
- 2000-08-08 AU AU74082/00A patent/AU7408200A/en not_active Abandoned
-
2002
- 2002-01-11 ZA ZA200200280A patent/ZA200200280B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN1368887A (zh) | 2002-09-11 |
WO2001012214A3 (en) | 2001-10-04 |
HUP0202525A2 (hu) | 2002-11-28 |
BR0013252A (pt) | 2002-04-16 |
AU7408200A (en) | 2001-03-13 |
HUP0202525A3 (en) | 2003-11-28 |
PL357367A1 (en) | 2004-07-26 |
MXPA02001296A (es) | 2002-07-22 |
PE20010490A1 (es) | 2001-04-27 |
TR200200401T2 (tr) | 2002-06-21 |
WO2001012214A2 (en) | 2001-02-22 |
JP2003507339A (ja) | 2003-02-25 |
RU2002105485A (ru) | 2004-01-27 |
CA2380653A1 (en) | 2001-02-22 |
EP1220683A2 (en) | 2002-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200107409B (en) | Fuel composition. | |
GB2349180B (en) | Inverted I.C.engine configuration | |
HK1069913A1 (en) | Generalized text localization in images. | |
MXPA01013362A (es) | Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso. | |
EG24361A (en) | 4-pyrimiding1-n-acy1.l.phenlalanines | |
ZA200200477B (en) | 2-pyrazolin-5-ones. | |
ZA200202537B (en) | Pour-on-formulations. | |
HK1053470A1 (en) | 4-Pyridinyln-acyl-l-phenylalanines. | |
ZA200110395B (en) | Catalytic cellulignin fuel. | |
MXPA02002209A (es) | Recipiente con mensaje. | |
ZA200200280B (en) | Mycophenolate mofetil in association with PEG-IFN-alpha. | |
ITRE990028A0 (it) | Integratore alimentare chelato ad uso agro-zootecnico, e metodo per l' ottenimento dello stesso. | |
HK1032814A1 (en) | Absorber. | |
IL147612A0 (en) | MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PREG-IFN-α | |
ZA200005803B (en) | Personal Watercraft Engine. | |
GB0029720D0 (en) | I.S machine7544232001 | |
ZA992018B (en) | Banners. | |
MXPA03003525A (es) | Concentrador de enlace posterior de enrutamiento escalable. | |
ZA200204581B (en) | Nitro-sulfobenzamides. | |
Jakubczak | Sankhja i joga. Podstawy filozofii Patańdżalego | |
Lysenko et al. | Maliariologiia | |
Tucker | Santamarian 1999 | |
HK1031254A1 (en) | Tachogragh. | |
Larsson-Kråik | Fullskalig testrigg: förstudie | |
Starčević et al. | Milanković juče danas sutra |